Search

Search Results

• 

  PO34 | INVESTIGATORS’ DECISIONS ON ANTICOAGULATION AFTER EXTENDED API-CAT TREATMENT FOR CANCER VENOUS THROMBOEMBOLISM I. Mahé^1|4, F. Happe², M. Monreal^5|7, H. Robert-Ebadi⁸, P. Debourdeau⁹, J. R. Fabreguettes¹⁰, S. Accassat¹¹, P. Mismetti^4|11|12, P. Girard¹³, S. Laporte^4|12|14, C. Chapelle¹⁴ | ¹Paris Cité University; ²Assistance Publique - Hôpitaux de Paris, Louis Mourier Hospital, Department of Internal Medicine; ³Inserm UMR-S970, Paris Cardiovascular Research Center, Team « Endotheliopathy and Hemostasis Disorders », Paris, France; ⁴F-CRIN INNOVTE Network, France; ⁵Department of Internal Medicine, Institut de Recerca Germans Trias i Pujol, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; ⁶Department of Medicine, Universitat Autonoma de Barcelona, Barcelona; ⁷Universidad Catolica San Antonio de Murcia, Murcia, Spain; ⁸Division of Angiology and Hemostasis, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland; ⁹Arles Hospital, Oncology unit, Arles, France; ¹⁰Assistance Publique - Hôpitaux de Paris, AGEPS, France; ¹¹Service de Médecine Vasculaire et Therapeutique, CHU de Saint-Etienne, Saint-Etienne, France; ¹²Université Jean Monnet, Mines Saint-Étienne, INSERM Unité 1059, Santé Ingénierie Biologie Saint-Étienne SAINBIOSE, Saint-Étienne, France; ¹³Département de Pneumologie, Institut Mutualiste Montsouris, Paris; ¹⁴Service de Pharmacologie Clinique, CHU de Saint-Etienne, Saint-Etienne, France

  Società Italiana di Emostasi e Trombosi

  16-04-2026

  https://doi.org/10.4081/btvb.2026.528

  117

  PDF: 21